Clinical Study
Tumor Regression Grades: Can They Influence Rectal Cancer Therapy Decision Tree?
Table 4
Comparison between TRG and demographic and clinic variables.
| Variables |
TRG1 + TRG2 | TRG3 + TRG4 + TRG5 | value |
| Sex | | | | Male | 42 (60%) | 45 (65.2%) | .52 | Female | 28 (40%) | 24 (34.7%) | Age | | | | Mean (range) | 63.1 | 66.1 | .12 | Tumor distance from anal verge | | | | >6 cm | 27 (38.5%) | 41 (59.4%) | .009 | ≤6 cm | 43 (61.4%) | 28 (40.5%) | Clinical stage | | | | II | 43 (61.4%) | 33 (47.8%) | .11 | III | 27 (38.5%) | 36 (52.1%) | Surgical procedure | | | | SSRR (sphincter saving rectal resection) | 40 (57.1%) | 48 (69.5%) | .13 | APR (abdominoperineal resection) + other (rectal resection without anastomose) | 30 (42.8%) | 21 (30.4%) | Pathological N-stage | | | | ypN0 | 61 (87.1%) | 36 (52.1%) | .001 | ypN+ | 9 (12.8%) | 33 (47.8%) | Pathological T-stage | | | | ypT0 − 2 | 42 (60%) | 7 (10.1%) | <.001 | ypT3 + 4 | 28 (40%) | 62 (89.9%) |
|
|